EXPERIENCE AND PROSPECTS OF CARBOXYTHERAPY IN DIABETES MELLITUS

Authors

DOI:

https://doi.org/10.21856/j-PEP.2021.4.15

Keywords:

Key words: diabetes mellitus, treatment, carboxytherapy.

Abstract

Diabetes mellitus (DM) is a global topical social problem of the XXI century.

The aim of this literature review is to analyze the physiological properties and pharmacotherapeutic possibilities of carboxytherapy, as well as the experience of this method for the treatment of diabetes.

Materials and methods. Scientific publications in foreign and domestic journals mainly for the last 5 years, online resources on carboxytherapy as a method of DM treating.

Results and discussions. As a result of the literature analysis, the mechanisms of implementation of the pharmacological effects with separate links of the pathogenesis of diabetes were compared. The mechanisms and effects of carboxytherapy as an effective alternative method for treating diabetes mellitus and its complications have been analyzed. The presented data indicate the rational use of carboxytherapy as an alternative method for treating diabetes and its complications.

Conclusions. Given the current possibilities of pharmacotherapy of diabetes and more than fifty years of experience in the use of carboxytherapy in practical medicine allows us to recommend this innovative method as an alternative to off-label therapy of diabetes.

Author Biography

Shtroblya А. L., Uzhgorod National University

Пошук і аналіз літературних джерел

References

Schmidt AM. Arterioscler Thromb Vasc Biol 2019;39(4): 558-568. https://doi.org/10.1161/ATVBAHA.119.310961.

da Rocha RB, Silva CS, Cardoso VS. Curr Diabetes Rev 2020;16(6): 598-607. https://doi.org/10.2174/1573399815666190702161849.

Kalra S, Chaudhary S. J Pak Med Assoc 2019;69(9): 1394-1395.

Singh R, Devi S, Gollen R. Diabetes Metab Res Rev 2015;31(2): 113-126. https://doi.org/10.1002/dmrr.2558. PMID: 24845883.

Gadjeva VG, Goycheva P, Nikolova G, Zheleva A. Adv Clin Exp Med 2017;26(8): 1237-1243. https://doi.org/10.17219/acem/68988.

Poblete-Aro C, Russell-Guzmán J, Parra P, et al. Rev Med Chil 2018;146(3): 362-372. https://doi.org/10.4067/s0034-98872018000300362.

Wei JP, Wang QH, Zheng HJ, Wei F. Chin J Integr Med 2018; 24(10): 723-727. https://doi.org/10.1007/s11655-018-2844-2.

American Diabetes Association. Diabetes Care 2018; 41(Suppl 1): S38-S50. https://doi.org/10.2337/dc18-S004. PMID: 29222375.

Drogovoz SM, Bunjatjan ND. Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul'tury 2018;95(5): 72-76.

Kalko KO, Drogovoz SM, Komarova AP, et al. Pharmacology online 2021;3: 179-186, available at: https://pharmacologyonline.silae.it/files/archives/2021/vol1/PhOL_2021_1_A024_Kalko.pdf

Drogovoz SM, Kalko KO, Hailat IA, et al. Pharmacology online 2 021;3: 4 47-455, a vailable at: https://pharmacologyonline.sila e.it/f iles/archives/2 021/vol1/PhOL_2021_1_A051_Drogovoz.pdf

Zelenková H. Glob Dermatol 2 017;4(1): 1 -5 h ttps://doi.org/10.15761/GOD.1000202.

Drogovoz SM, et al. Farmakologija i lekarstvennaja toksikologija 2016;6(51): 12-20.

Zelenkova H. J Clin Cell Immunol 2016;7(5): 33.

Xi L, Chow CM, Kong X. J Diabetes Res 2016;2016: 1527852. https://doi.org/10.1155/2016/1527852.

Drogovoz SM, et al. Racional'naja farmakoterapija 2016;1: 37-39.

Feldman EL, Callaghan BC, Pop-Busui R, et al. Nat Rev Dis Primers 2019;5(1): 42. https://doi.org/10.1038/s41572-019-0097-9.

Dewanjee S, Das S, Das AK, et al. Eur J Pharmacol 2018;833: 472-523. https://doi.org/10.1016/j.ejphar.2018.06.034.

Zeng Y, Cao D, Yu H, et al. Br J Ophthalmol 2019; 103(12): 1747-1752. https://doi.org/10.1136/bjophthalmol-2018-313582.

Zbroja H, Kowalski M, Lubkowska A. Int J Environ Res Public Health 2021;18(4): 1490. https://doi.org/10.3390/ijerph18041490.

Cryer MJ, Horani T, DiPette DJ. J Clin Hypertens (Greenwich) 2016;18(2): 95-100. https://doi.org/10.1111/jch.12638.

Pagourelias ED, Zorou PG, Tsaligopoulos M, et al. Int J Biometeorol 2011;55(5): 657-663. https://doi.org/10.1007/s00484-010-0380-7.

Kotenko KV, Esipov AV, Yamenskov VV. Voen Med Zh 2016;337(9): 32-37.

França EL, Ribeiro EB, Scherer EF, et al. Biomed Res Int 2014; 2014: 840379. https://doi.org/10.1155/2014/840379.

Gabunia T, Turabelidze-Robaqidze S, Sujashvili R, et al. Georgian Med News 2015;(248): 39-45.

Gabreanu GR, Angelescu S. Discoveries (Craiova) 2016; 4(2): e60. https://doi.org/10.15190/d.2016.7.

Sawada S, Tsuchiya S, Kodama S, et al. Diabetes Res Clin Pract 2 020; 1 65: 1 08240. https://doi.org/10.1016/j.diabres.2020.108240.

Hussain J, Cohen M. Evid Based Complement Alternat Med 2018;2018: 1857413. https://doi.org/10.1155/2018/1857413.

Gerasimenko EN, Meshchaninov VN, Zvezdina EM, et al. Adv Gerontol 2014;27(3): 477-483.

Shalan N, Al-Bazzaz A, Al-Ani I, et al. J Diab Mellitus 2015; 5(4): 284-289. https:/doi.org/10.4236/jdm.2015.54035.

Kenichi Otsuguro, Sumiko Yasutake, Yoshihiko Yamaji, et al. Jap Soc Alternat Animal Experim 2008;14:101-106.

Downloads

Published

2021-12-03

How to Cite

Дроговоз, С., Бєлік, Г., Калько, К., Шевченко, С., Деримедвідь, Л., Кіреєв, І., & Штробля, А. (2021). EXPERIENCE AND PROSPECTS OF CARBOXYTHERAPY IN DIABETES MELLITUS. Problems of Endocrine Pathology, 78(4), 110-116. https://doi.org/10.21856/j-PEP.2021.4.15